Here we describe the application of novel lipidized peptidomimetic conjugate SA-5 as a ligand (Figure 1) for the preparation of liposomal chemotherapeutics targeted toward human epidermal growth factor receptor -2 (HER2) overexpressed cancer cells. This evidence concerns the gene ERBB2 and cancer.